Lipocine Inc. Quarterly Net Cash Provided by (Used in) Financing Activities in USD from Q1 2017 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Lipocine Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from Q1 2017 to Q1 2024.
  • Lipocine Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was -$8.1K.
  • Lipocine Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $405K.
  • Lipocine Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was -$2.13M, a 108% decline from 2021.
  • Lipocine Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $26.9M, a 28.8% increase from 2020.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$8.1K* +$6.01M Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q1 2023 -$6.02M -$5.39M -859% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q1 2022 -$627K -$30.1M -102% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q1 2021 $29.4M +$24.6M +503% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q1 2020 $4.88M -$350K -6.68% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q1 2019 $5.23M -$4.77M -47.7% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q1 2018 $10M +$6.91M +224% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q1 2017 $3.09M Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.